Humana Inc vs BlackRock TCP Capital Corp — how do they compare? Humana Inc trades at $437.84 (market cap $47.61B), while BlackRock TCP Capital Corp trades at $4.04 (market cap $332.25M). The key difference: Humana Inc is far larger — about 143.3× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays the higher dividend (19.19%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and BlackRock TCP Capital Corp for 88 Days on average.
| HUM | TCPC | |
|---|---|---|
Market Cap | $47.61B | $332.25M |
Volume | 1,827,332 | 567,148 |
Sector | Health | Financials |
52-Week High | $409.85 | $6.20 |
52-Week Low | $163.67 | $3.13 |
Typical Hold Time | 53 Days | 88 Days |
Enterprise Value | $54.97B | $1.08B |
Dividend Yield | 0.89% | 19.19% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
TCPC trades at $3.94, down 1.25% with a bearish technical outlook. The company reported negative revenue and net income trends from 2024-2026, though recent Q2 2026 earnings beat expectations. A strategic portfolio sale of $523 million aims to reduce leverage and improve liquidity. Analyst sentiment is mixed with 30.77% buy ratings but predominantly hold recommendations.
TCPC faces significant fundamental challenges with declining revenue and negative profitability metrics. The ongoing strategic review and portfolio cleanup may offer long-term value, but investors should weigh the high dividend yield against persistent negative cash flow and earnings trends. Key risks include execution of the strategic review and broader private credit market conditions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →